Literature DB >> 10402061

Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease.

C Giannini1, F Giannelli, M Monti, G Careccia, M E Marrocchi, G Laffi, P Gentilini, A L Zignego.   

Abstract

Multiple infection by different hepatitis C virus (HCV) genotypes may be of great clinico-pathologic interest. In this study we determined the effective prevalence of coinfections by two or more HCV genotypes in 213 subjects with HCV-positive chronic hepatitis by using genotype-specific polymerase chain reaction (PCR), genotype-specific probe hybridization, and direct sequencing. The most prevalent genotype was HCV-1b (54%). HCV-2 (a/c) was also prevalent (27%), and types 1a and 3a were found in 5% and 3% of patients, respectively. A mixed infection was detected in 23 patients (10.8%): 4 out of 23 were coinfected by types 1a + 1b, while the remaining 19 patients had a b + 2 (a/c) mixed infection. Further analysis based on restriction fragment length polymorphism (RFLP) on type-specific PCR products was used to verify genotyping results. Only four coinfections (1a + 1b in 2 patients and 1b + 2 (a/c) in the remaining 2 patients, respectively) were confirmed by enzyme cleavage. All patients with true coinfection had long-lasting infection and liver cirrhosis. Both true and false mixed infections resulting from RFLP analysis were confirmed by direct sequencing of type-specific amplification products. We also determined a recurrent C/T transversion at position 618 in all sequenced samples. In 4 cases another point mutation (G/A at position 626) was found, reducing the number of mismatches between HCV-2 and HCV-1b from 4 to 3 (or 2). Interestingly, all HCV-2 isolates sequenced showed the highest degree of nucleotide homology with HCV-2 subtype c, confirming the relatively high prevalence of this subtype in Italy. In conclusion, we showed the possibility of multiple infection by different HCV types in the general population of chronically infected patients without particular risk factors, even if in a low percentage of cases. Further studies are needed to assess the clinical relevance of chronic HCV infection with multiple genotypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10402061     DOI: 10.1016/s0022-2143(99)90055-0

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

1.  Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes.

Authors:  Alejandro Schijman; Rodney Colina; Sergey Mukomolov; Olga Kalinina; Laura García; Shobha Broor; Ajoy Varma Bhupatiraju; Peter Karayiannis; Baldip Khan; Cristina Mogdasy; Juan Cristina
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  An experimental test of the independent action hypothesis in virus-insect pathosystems.

Authors:  Mark P Zwart; Lia Hemerik; Jenny S Cory; J Arjan G M de Visser; Felix J J A Bianchi; Monique M Van Oers; Just M Vlak; Rolf F Hoekstra; Wopke Van der Werf
Journal:  Proc Biol Sci       Date:  2009-03-11       Impact factor: 5.349

3.  Multitypic hepatitis C virus infection identified by real-time nucleotide sequencing of minority genotypes.

Authors:  Andrew J Buckton; Siew-Lin Ngui; Catherine Arnold; Katie Boast; Joanne Kovacs; Paul E Klapper; Bharat Patel; Imad Ibrahim; Savita Rangarajan; Mary E Ramsay; Chong-Gee Teo
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 4.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

5.  Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial.

Authors:  Lucivalda P M Oliveira; Rosangela P de Jesus; Ramona S S B Boulhosa; Carlos Mauricio C Mendes; Maria Cecilia Gnoatto; Denise C Lemaire; Maria Betania P Toralles; Lourianne N Cavalcante; Andre C Lyra; Luiz G C Lyra
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

6.  Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes.

Authors:  Linda Cook; KaWing Sullivan; Elizabeth M Krantz; Arthur Bagabag; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

7.  A shift in the hepatitis C virus genotype dominance in blood donor samples from Thailand.

Authors:  Anchalee Sistayanarain; Duangkamol Kunthalert; Yaovaluk Vipsoongnern
Journal:  Mol Biol Rep       Date:  2010-11-27       Impact factor: 2.316

8.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

9.  Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance.

Authors:  C Mazzeo; F Azzaroli; S Giovanelli; A Dormi; D Festi; A Colecchia; A Miracolo; P Natale; G Nigro; A Alberti; E Roda; G Mazzella
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

10.  Recombination in hepatitis C virus: identification of four novel naturally occurring inter-subtype recombinants.

Authors:  Weifeng Shi; Ines T Freitas; Chaodong Zhu; Wei Zheng; William W Hall; Desmond G Higgins
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.